SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Jun-23 4:27 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 01-Jun-23 | Disposition | 24,092 | -- | -- | (100%) 24.09K to 0 | |
13-Dec-22 8:24 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 13-Dec-22 | Sale (Planned) | 1,659 | $1.07 | $1,766.84 | (3%) 54.67K to 53.01K | |
13-Dec-22 8:24 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 12-Dec-22 | Sale (Planned) | 1,610 | $1.10 | $1,766.17 | (3%) 56.28K to 54.67K | |
13-Dec-22 8:24 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 09-Dec-22 | Sale (Planned) | 1,561 | $1.13 | $1,765.49 | (3%) 57.84K to 56.28K | |
09-Dec-22 4:42 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 08-Dec-22 | Sale (Planned) | 1,410 | $1.25 | $1,766.73 | (2%) 62.04K to 60.63K | |
09-Dec-22 4:42 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 07-Dec-22 | Sale (Planned) | 1,378 | $1.28 | $1,766.60 | (2%) 63.42K to 62.04K | |
07-Dec-22 7:56 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 06-Dec-22 | Sale (Planned) | 1,327 | $1.33 | $1,764.91 | (2%) 67.36K to 66.04K | |
07-Dec-22 7:56 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 05-Dec-22 | Sale (Planned) | 1,291 | $1.37 | $1,766.09 | (2%) 68.66K to 67.36K | |
05-Dec-22 7:50 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 02-Dec-22 | Planned Option Sale | 1,273 | $1.39 | $1,765.65 | (3%) 37.79K to 36.52K | |
05-Dec-22 7:50 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 01-Dec-22 | Option Exercise | 33,409 | -- | -- | 762% 4.38K to 37.79K |